Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial
A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published on Friday.
from bdnews24.com - Home https://ift.tt/36lOFEv
from bdnews24.com - Home https://ift.tt/36lOFEv
No comments